← Back to Investors

M Ventures

M Ventures is the strategic corporate venture capital arm of Merck KGaA, Darmstadt, Germany. They invest in transformative life sciences companies with a focus on areas aligned with Merck's strategic interests, including healthcare, life science tools, and electronics.

Location
Amsterdam, Netherlands
Founded
2009
AUM
€400M+
Investment Range
€5M - €50M
Focus
cvc
Fund Stages
seed, series-a, series-b, series-c, growth

Investment Thesis

M Ventures invests in innovative companies at the forefront of scientific discovery. In healthcare, they focus on therapeutics, diagnostics, and life science tools that have the potential to transform patient care and accelerate scientific research. They bring strategic partnership opportunities with Merck alongside financial investment.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Andy Sandford - Managing Director
  • Hendrik Liebers - Partner
  • Matthias Kromayer - Partner

Other Key Team Members

  • Investment team with deep scientific backgrounds

Focus Areas

  • Therapeutics (oncology, immunology)
  • Life science tools
  • Diagnostics
  • Digital health
  • Synthetic biology
  • Lab automation
  • Drug discovery platforms

Notable Exits

  • BioNTech - IPO (2019, mRNA therapeutics)
  • Multiple strategic acquisitions by Merck
  • Strong track record in life science tools

Sources